News

Mustafa Bashir, MD presents at RSNA 2016 Thursday Dec 1

SSQ06-04 Intravenous Gadoxetate Disodium Administration Reduces Breath-Holding Capacity in the Hepatic Arterial Phase – A Multi-Center Randomized Placebo-Controlled Trial 11:10 a.m. – 11:20 a.m. E350

Mustafa Bashir, M.D.

SHARE: